Search

Use the search bar or filters below to find any TAPPI product or publication.

Showing 2 results (Duration : 0.011 seconds)
TAPPI News
TAPPISAFE® Kicks Off Tenth Anniversary During National Safety Month

As the first industry-recognized and designed safety orientation and verification program, TAPPISAFE has implemented over one million standardized safety tests since 2012

Journal articles
Magazine articles
Open Access
Evaluation of rice straw for purification of lovastatin, TAPPI Journal November 2021

ABSTRACT: Cholesterol synthesis in the human body can be catalyzed by the coenzyme HMG-CoA reductase, and lovastatin, a key enzyme inhibitor, can reduce hypercholesterolemia. Lovastatin can be obtained as a secondary metabolite of Aspergillus terreus ATCC 20542. In this study, rice straw of lignocellulose was used in aeration and agitation bath fermentation in a 1-L flask, and a maximal crude extraction rate of 473 mg/L lovastatin was obtained. The crude extract was treated with silica gel (230–400 mesh) column chromatography. Ethyl acetate/ethanol (95%) was used as the mobile phase, and isolation was performed through elution with various ethyl acetate/ethanol ratios. The highest production rate of 153 mg/L was achieved with ethyl acetate/ethanol in a ratio of 8:2. The lovastatin gained from the crude extract was added to 12 fractions treated with 0.001 N alkali, and acetone was then added. After 24 h of recrystallization at 4°C, the extract underwent high-performance liquid chromatography. The purity had increased from 25% to 84.6%, and the recovery rate was 65.2%.

  • Page 1 of 1